This may result in you starting at a lower strength to reduce the potential impact of side effects and facilitate a safe transition
According to their UK SmPCs, these medications should not be used during breast-feeding
According to researchers, weight reduction is quicker in the first 6 months, and slows after that, plateauing at 12-18 months
Medicare GLP-1 Bridge program Beginning July 1, 2026 through December 31, 2027, eligible Medicare beneficiaries can access the following FDA-approved GLP-1 medications for weight loss : Wegovy (injection or tablet), Foundayo (tablet), and Zepbound (KwikPen only) for $50/month *** through the Medicare GLP-1 Bridge program
Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction
They can assess your overall health, calculate your BMI, review any relevant comorbidities such as type 2 diabetes or hypertension, and determine whether you meet the criteria for referral to a specialist weight management service (Tier 3 or Tier 4)
